Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Pharmaceuticals, Inc. is a global, research-driven pharmaceutical company that focuses on developing innovative therapies to improve the health and quality of life of patients. Founded in 1885, the company has a long history of scientific excellence and a commitment to addressing unmet medical needs.

Sustainability

Boehringer Ingelheim is committed to sustainability and has implemented various initiatives to reduce its environmental impact. The company publishes an annual ESG (Environmental, Social, and Governance) report that outlines its efforts in areas such as carbon footprint reduction, waste management, and sustainable sourcing. Boehringer Ingelheim has also received several sustainability certifications and accreditations, demonstrating its commitment to environmental stewardship.

• Annual ESG reports available
• Focus on carbon footprint reduction
• Sustainable sourcing initiatives
• Multiple sustainability certifications